[Federal Register Volume 69, Number 82 (Wednesday, April 28, 2004)]
[Notices]
[Page 23210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-9569]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Public Meeting

AGENCY: National Institutes of Health, DHHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) is announcing a public 
meeting to enable invited individuals, organizations, and other 
stakeholders to comment on the use of the government march-in 
authorities under 35 U.S.C. 203 for Norvir[reg] (ritonavir) 
manufactured by Abbott Laboratories using inventive technologies 
developed with NIH funds.
    Time and Date: The public meeting will be held on May 25, 2004 from 
9 a.m. to 12 p.m.
    Place: The public meeting will be held in the first-floor 
conference room, Building 50 (at the corner of Center and South 
Drives), National Institutes of Health, 9000 Rockville Pike, Bethesda, 
MD 20892. Parking will be limited and there may be delays entering the 
NIH campus due to increased security. We recommend arriving by Metro, 
if possible. NIH is accessible from the Metro's red line at the Medical 
Center/NIH stop.

FOR FURTHER INFORMATION CONTACT: Mary Martinez, Office of Technology 
Transfer, Office of the Director, National Institutes of Health, 6011 
Executive Blvd, Suite 325, Rockville, MD 20852, e-mail: 
[email protected]
    Registration and Participation: No registration is required to 
attend the public meeting. Seating will be on a first-come, first-serve 
basis.
    Participation as a presenter is by invitation only. The agency will 
notify each invited speaker of the time allotted to the participant and 
the approximate time the participant's comments are scheduled to begin.
    If you need special accommodations due to disability, please inform 
Mary Martinez, the contact person listed in this document.

    Dated: April 22, 2004.
Mark L. Rohrbaugh,
Director, Office of Technology Transfer, National Institutes of Health.
[FR Doc. 04-9569 Filed 4-27-04; 8:45 am]
BILLING CODE 4140-01-P